Maze Therapeutics, Inc Common Stock

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$0
$0
$0
$2,500
Gross Profit
-649
-684
-705
2,500
EBITDA
-36,474
-35,401
-29,021
-23,441
EBIT
-36,085
-29,726
-24,229
Net Income
-33,679
-32,786
-29,579
-24,752
Net Change In Cash
0
0
0
2,500
Free Cash Flow
-30,445
-29,815
-23,057
-23,308
Cash
264,541
294,374
196,812
149,607
Basic Shares
43,850
43,797
43,796
43,776

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31
Revenue
$167,500
$0
$0
Gross Profit
167,500
-4,089
-3,820
EBITDA
60,883
-94,462
-107,206
EBIT
57,586
-98,551
-111,026
Net Income
52,231
-100,415
-114,940
Net Change In Cash
167,500
0
0
Free Cash Flow
74,807
-87,268
-101,169
Cash
196,812
29,158
99,919
Basic Shares
43,796
43,776
43,776

Earnings Calls

Quarter EPS
2025-06-30
-$0.76
2025-03-31
-$0.74